PNC Financial Services Group
ADMA icon

PNC Financial Services Group’s ADMA Biologics ADMA Stock Holding History

PNC Financial Services Group’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.5K Sell
10,211
-2,729
-21% -$24.9K ﹤0.01% 3032
2026
Q1 		$117K Sell
12,940
-22,587
-64% -$356K ﹤0.01% 2704
2025
Q4 		$648K Sell
35,527
-7,963
-18% -$134K ﹤0.01% 1482
2025
Q3 		$638K Buy
43,490
+15,792
+57% +$271K ﹤0.01% 1494
2025
Q2 		$504K Buy
27,698
+4,373
+19% +$89.2K ﹤0.01% 1551
2025
Q1 		$463K Buy
23,325
+4,553
+24% +$78.7K ﹤0.01% 1572
2024
Q4 		$322K Buy
18,772
+2,279
+14% +$42.9K ﹤0.01% 1857
2024
Q3 		$330K Buy
16,493
+16,364
+12,685% +$254K ﹤0.01% 1832
2024
Q2 		$1.44K Buy
129
+95
+279% +$797 ﹤0.01% 4343
2024
Q1 		$224 Buy
34
+9
+36% +$49 ﹤0.01% 4597
2023
Q4 		$113 Buy
+25
New +$92 ﹤0.01% 4514
2021
Q3 		– Sell
-1,600
Closed -$2K – 4280
2021
Q2 		$2K Buy
+1,600
New +$2.81K ﹤0.01% 4011

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

PNC Financial Services Group's ADMA Position: Q2 2026 in Review

PNC Financial Services Group reduced its ADMA Biologics (ADMA) stake by 21% in Q2 2026, selling an estimated $24.9K and leaving 10,211 shares worth $85.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3032.

PNC Financial Services Group first reported a position in ADMA in Q2 2021 and has held it in 12 quarters since. The position peaked at $648K in Q4 2025. 141 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • PNC Financial Services Group held 10,211 shares of ADMA Biologics worth $85.5K as of Q2 2026.
  • PNC Financial Services Group sold 2,729 ADMA Biologics shares in Q2 2026, an estimated $24.9K.
  • ADMA Biologics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3032 holding.
  • PNC Financial Services Group first reported a position in ADMA Biologics in Q2 2021 and has held it in 12 quarters since.
  • PNC Financial Services Group's ADMA Biologics position peaked at $648K in Q4 2025.
  • 141 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.